McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies. Its core expertise covers Therapeutic Peptides and Proteins, Antibodies, and Drug Conjugates. The team has a strong background in synthetic selective chemistry, and a real expertise in bioconjugation, including specific designs of Antibody Drug Conjugates (ADCs) with own proprietary coupling technology. Plus, the company has now a pipeline of three products in oncology incorporating McSAF Inside technology with the ambition to bring new biodrugs on the market solving unmet medical needs.
| Website | http://mcsaf.fr |
| Employees | 4 (4 on RocketReach) |
| Founded | 2015 |
| Phone | +33 2 47 25 00 26 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Targeted Therapies, Therapeutic Peptides, Bioorganic Chemistry, Biotechnology, Drug Development, Drug Discovery, Antibodies, Pharmaceutical Research, Therapeutics, Peptides, Innovative Technologies, Life Sciences, Pharmaceutical, Organic Chemistry, Deeptech, Chemistry |
| Competitors | Siemens, Honeywell, Schneider Electric, Eaton, Parker Hannifin, Bosch Rexroth, Festo, IMI, HYDAC India- Hydraulics, Systems and Fluid Engineering, Cavotec +37 more (view full list) |
Looking for a particular McSAF employee's phone or email?
Marie-Claude Viaud-Massuard is the Chief Scientific Officer of McSAF.
4 people are employed at McSAF.